Hong Kong offers 500,000 free air tickets to tempt tourists back
Editor's Note — Sign up for Unlocking the World, CNN Travel's weekly newsletter. Get news about destinations opening, inspiration for...
Social Impact
Get Vaccinated Ahead of Holiday Gatherings
With the holidays right around the corner, San Diegans are reminded to schedule their COVID-19 booster and flu vaccines as...
Report says COVID-19 pandemic impacted number of HIV cases, resources, treatments in US
SAN FRANCISCO (KGO) -- A new report found that the COVID-19 pandemic has had a negative impact on the number...
Bay Area COVID cases level off, California numbers hit a plateau
After a precipitous drop over the past two months, California’s COVID-19 trends have hit a plateau. The state reported an...
COVID-19 Travel Restrictions Ease in Many Countries
Due to a variety of factors, including epidemiological, economic, and political considerations, many countries are dropping their COVID-19 pandemic-related travel...
/cloudfront-us-east-1.images.arcpublishing.com/gray/7P735CXZWRGCTNLSFUXY4Y6IZI.bmp "Feds trying to seize two Louisville buildings connected to 0 million COVID fraud")
Feds trying to seize two Louisville buildings connected to $250 million COVID fraud
LOUISVILLE, Ky. (WAVE) - The feds are trying to seize a Louisville mosque and health clinic.The government said the buildings...
COVID-19 levels flat in Minnesota ahead of cold and flu season
COVID-19 surged in September in each of the past two years in Minnesota, but Thursday's weekly state update showed little...
Clinical characteristics and outcomes of patients undergoing extracorporeal membrane oxygenation for COVID-19 acute respiratory distress syndrome
In a recent study published in ASAIO Journal, researchers comparatively assessed mortality rates among CARDS patients on ECMO (extracorporeal membrane...
Merck Covid antiviral pill did not cut hospitalisation risk, study finds
Merck’s Covid-19 antiviral pill failed to show it can lower the risks of hospitalisation and death among adults at higher...
German COVID vaccine developer BioNTech signs research deal with Australia
SYDNEY, Oct 7 (Reuters) - BioNTech SE, the German biotech that developed a widely used COVID-19 vaccine with Pfizer Inc,...